Business Wire05.30.16
Ortho Kinematics Inc. (OKI) has received Health Canada authorization for its lead product, Vertebral Motion Analysis (VMA). The VMA is now licensed for sale in Canada, expanding the VMA’s current list of markets, which include the United States and Europe.
“Expanding into Canada is a big step forward in positioning the VMA as a global standard of care for assessing spinal motion and instability.” OKI CEO Paul Gunnoe said. “We believe Canadian patients and their providers stand to benefit significantly.”
The VMA is a diagnostic test for the assessment of spinal motion and radiographic instability. Today’s current test for assessing spinal radiographic instability is ordered more than 5 million times annually in the United States, largely by spine surgeons, because it provides diagnostic data that is necessary for many patients being considered for potential spine surgery. Relative to the current standard test, the VMA has been shown in peer-reviewed studies to increase the sensitivity in detecting radiographic instability with no decrease in specificity. Furthermore, the VMA has shown to be more accurate, repeatable and result in a lower dose of radiation.
OKI plans to begin offering the VMA in Canada later this year, limiting initial distribution to a select group of spine care institutions.
Ortho Kinematics is a privately held diagnostic technology company based in Austin, Texas, that is focused on spine imaging informatics.
“Expanding into Canada is a big step forward in positioning the VMA as a global standard of care for assessing spinal motion and instability.” OKI CEO Paul Gunnoe said. “We believe Canadian patients and their providers stand to benefit significantly.”
The VMA is a diagnostic test for the assessment of spinal motion and radiographic instability. Today’s current test for assessing spinal radiographic instability is ordered more than 5 million times annually in the United States, largely by spine surgeons, because it provides diagnostic data that is necessary for many patients being considered for potential spine surgery. Relative to the current standard test, the VMA has been shown in peer-reviewed studies to increase the sensitivity in detecting radiographic instability with no decrease in specificity. Furthermore, the VMA has shown to be more accurate, repeatable and result in a lower dose of radiation.
OKI plans to begin offering the VMA in Canada later this year, limiting initial distribution to a select group of spine care institutions.
Ortho Kinematics is a privately held diagnostic technology company based in Austin, Texas, that is focused on spine imaging informatics.